Diplomat Pharmacy Inc (NYSE: DPLO), an independent provider of specialty pharmacy and infusion services, announced yesterday that it has named Dave Loschinskey as its new chief operating officer effective 2 May.
Prior to being appointed to chief operating officer, Loschinskey served as the company's chief information officer. He has 27 years of experience in technology and software development, with a focus on the specialty pharmacy industry.
Prior to joining Diplomat, he founded and served as chief executive officer of 8th Day Software and Consulting LLC, a software vendor focused on developing technologies--including for patient engagement, pharma reporting, hub management and oncology treatment and pathway tracking--and providing IT outsourcing and consulting for healthcare companies, from May 2013 until its acquisition by the company in October 2017. Before founding 8th Day Software, he held a variety of leadership roles at Accredo Health, including vice president of business innovation and chief information officer.
Bioforum, The Data Masters names new President
VolitionRx names new Chief Medical Officer
Quotient Sciences announces new appointments
Syndax Pharmaceuticals names new chief commercial officer
Everest Medicines names new chief medical officer and chief product officer
D3 Bio names new independent board member
Rigel Pharmaceuticals names new executive vice president and chief medical officer
Telix Pharmaceuticals names new group chief operating officer